###begin article-title 0
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Prevention of elastase-induced emphysema in placenta growth factor knock-out mice
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 25 30 <span type="species:ncbi:9606">human</span>
Although both animal and human studies suggested the association between placenta growth factor (PlGF) and chronic obstructive pulmonary disease (COPD), especially lung emphysema, the role of PlGF in the pathogenesis of emphysema remains to be clarified. This study hypothesizes that blocking PlGF prevents the development of emphysema.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
Pulmonary emphysema was induced in PlGF knock-out (KO) and wild type (WT) mice by intra-tracheal instillation of porcine pancreatic elastase (PPE). A group of KO mice was then treated with exogenous PlGF and WT mice with neutralizing anti-VEGFR1 antibody. Tumor necrosis factor alpha (TNF-alpha), matrix metalloproteinase-9 (MMP-9), and VEGF were quantified. Apoptosis measurement and immuno-histochemical staining for VEGF R1 and R2 were performed in emphysematous lung tissues.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
After 4 weeks of PPE instillation, lung airspaces enlarged more significantly in WT than in KO mice. The levels of TNF-alpha and MMP-9, but not VEGF, increased in the lungs of WT compared with those of KO mice. There was also increased in apoptosis of alveolar septal cells in WT mice. Instillation of exogenous PlGF in KO mice restored the emphysematous changes. The expression of both VEGF R1 and R2 decreased in the emphysematous lungs.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 121 125 <span type="species:ncbi:10090">mice</span>
In this animal model, pulmonary emphysema is prevented by depleting PlGF. When exogenous PlGF is administered to PlGF KO mice, emphysema re-develops, implying that PlGF contributes to the pathogenesis of emphysema.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th </sup>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 390 392 390 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 399 401 399 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 896 897 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 898 899 898 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
Chronic obstructive pulmonary disease (COPD) affects over 18 million Americans and is the 4th leading cause of death in the US. The disease burden will continue to increase globally as smoking rates climb in most developing countries [1]. Emphysema, a major component of COPD, is characterized by variable inflammatory cell infiltration, including neutrophils, alveolar macrophages, and CD4+ and CD8+ lymphocytes, as well as the presence of proteinase-anti-proteinase imbalance within the alveolar space, which leads to destruction and permanent enlargement of peripheral lung airspaces [2-6]. Pulmonary emphysema is defined as the abnormal enlargement of respiratory spaces with destruction of the alveolar walls. Experimental evidence supports the concept that proteases from activated macrophages and neutrophils degrade elastin and other structural proteins, thereby damaging alveolar units [5,7].
###end p 10
###begin p 11
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 284 287 284 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 213 221 <span type="species:ncbi:9606">patients</span>
###xml 366 370 <span type="species:ncbi:10116">rats</span>
###xml 375 381 <span type="species:ncbi:9606">humans</span>
The "vascular hypothesis" of COPD is corroborated by a recent study showing that protein levels and messenger ribonucleic acid (mRNA) expression of both VEGF and its receptor are decreased in lung tissues of COPD patients [8]. Moreover, cigarette smoke disrupts components of the VEGF165-VEGFR2 and decreases the expression of VEGF and its receptors in the lungs of rats and humans [9]. Thus, VEGF signaling is considered mandatory for the maintenance of alveolar structures.
###end p 11
###begin p 12
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 276 284 276 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 454 469 <span type="species:ncbi:10090">transgenic mice</span>
###xml 574 579 <span type="species:ncbi:9606">human</span>
###xml 659 667 <span type="species:ncbi:9606">patients</span>
Placenta growth factor (PlGF) is an angiogenic growth factor, which is a 50-kDa glycosylated dimeric protein sharing 53% sequence homology at the amino acid level with VEGF [10]. Like VEGF, it exhibits mitogenic activity in cultured endothelial cells and induces angiogenesis in vivo [11]. PlGF mRNA is abundant in the placenta, thyroid, and lungs [12], but its biologic function in these tissues remains largely unclear. A previous study involving PlGF-transgenic mice demonstrates significantly enlarged air spaces and enhanced pulmonary compliance, a situation mimicking human pulmonary emphysema [13]. The increased PlGF expression was also shown in COPD patients [14].
###end p 12
###begin p 13
###xml 35 50 <span type="species:ncbi:10090">transgenic mice</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
Based on our previous results from transgenic mice and human subjects, it is postulated that PlGF may be involved in the inflammatory process related to emphysema. This study aimed to test this hypothesis by determining whether emphysema could be prevented in mice whose PlGF had been knocked out. It further aimed to elucidate the role of PlGF in the pathogenesis of emphysema.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Animals
###end title 15
###begin p 16
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
The Animal Care and Use Committee of the National Taiwan University Hospital approved the following animal protocol. Breeding couples of wild-type (PlGF +/+), heterozygous type (PlGF +/-), and PlGF knock-out type (PlGF-/-) mice in a 50% 129Sv x 50% Swiss background were performed as described [15]. These mice were available from the Dr. Peter Carmeliet's animal lab. In breeding rooms, we maintained on a 12-hr light and dark cycle with constant temperature and humidity.
###end p 16
###begin title 17
Experimental animals and PPE-induced emphysema
###end title 17
###begin p 18
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
The129/sw mice were anesthetized with intra-peritoneal urethane (120 mg/100 g) and given porcine pancreatic elastase (PPE) (Worthington; Biochem) at 4 mg/kg or saline (0.9% NaCl) alone via intra-tracheal instillation every week. These mice were then divided into 4 groups (n = 5 each), including the wild type (PlGF +/+, WT with PPE), heterozygous deficient (PlGF +/-, HE with PPE), homozygous deficient (PlGF -/-, KO with PPE), and control (PlGF +/+, PlGF +/- and PlGF -/- with saline; C, C+/- and C-/-, respectively). After 4 weeks of continuous treatment, the mice were sacrificed for study. After being anesthetized and exsanguinated, their lungs were inflated until visibly taut (maximum volume) with freshly prepared paraformaldehyde through tracheal cannula. The maximum volume was maintained for at least 2 minutes before the trachea was tied-off to maintain inflation. Two transverse tissue slabs were cut from the lungs and one from the right caudal lobe. The same locations were sampled in all mice. These tissues were embedded in paraffin and 4-mum serial sections were cut, individually handled and numbered, and transferred on to the slides.
###end p 18
###begin p 19
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
Second, the PlGF KO mice were evaluated if they could re-develop emphysema. In these mice, PPE instillation followed by exogenous PlGF at 1 mg/kg dose via intra-tracheal route was done weekly. After 4 weeks, these KO mice were studies for measurement of airspace enlargement.
###end p 19
###begin p 20
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
Third, the PlGF WT mice were instilled with PPE followed by VEGF R1 blocker agent (neutralizing antibody against mouse VEGF-R1, AF471; R&D Systems) at a dose of 10 mug/kg every week. After 4 weeks, these mice were sacrificed to measure emphysema development.
###end p 20
###begin title 21
Morphologic evaluation and quantification of emphysema
###end title 21
###begin p 22
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 551 564 551 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v(air, lung) </sub>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
Quantitative histological measurements were made using an image analysis system, consisting of an Olympus CCD camera (Olympus, Tokyo, Japan). From each field, five areas of interest, free of airway and muscular blood vessels, were picked for measuring the number of intersections of virtual lines of known length with alveolar septa [16]. An increase in the average distance between Mean Linear Intercept (MLI) indicates enlarged airspaces. The areas of interest were also analyzed for tissue area and lung-air area. Volume density of the airspace (V v(air, lung) %) was also measured [17].
###end p 22
###begin title 23
Expression of inflammatory mediators and VEGF in bronchoalveolar lavage by ELISA
###end title 23
###begin p 24
A 22-gauge cannula was inserted into the trachea, and both lungs were lavaged five times with 0.8 ml of PBS. The collected fluid was centrifuged at 400 x g for 10 minutes. The supernatant (bronchoalveolar lavage fluid) were divided into aliquots and stored at -80degreesC until analysis. The quantification for TNF-alpha, MMP-9 and VEGF were assayed by standardized sandwich enzyme-linked immunosorbent assay (ELISA) method (R&D Systems, Minneapolis, MN, USA) in duplicate according to the manufacturer's protocol.
###end p 24
###begin title 25
Western Blot analysis for TNF-alpha, MMP-9, VEGF, VEGFR1 and VEGFR2
###end title 25
###begin p 26
###xml 683 687 <span type="species:ncbi:9925">goat</span>
###xml 692 703 <span type="species:ncbi:3704">horseradish</span>
###xml 728 731 <span type="species:ncbi:9685">Cat</span>
Excised lungs were homogenized in a solution containing 1 mM EDTA, 0.5 mM aminoethylbenezenesulfonyl fluoride (AEBSF), 1 mug/ml Leupeptin, 1 mug/ml Aprotinin, 10 mug/ml Trypsin-Chymotrypsin inhibitor, 1 mug/ml Pepstatin A (all from Sigma). Proteins were resolved on 10% polyacrylamide gel and Western blots performed using standard techniques. Membranes were incubated overnight at 4degreesC with the following antibodies from Santa Cruz Biochemicals (Santa Cruz, CA): anti-MMP-9 diluted 1:500; anti-TNF-alpha diluted 1: 1000; anti-VEGF diluted 1: 1000; anti-VEGFR1 diluted 1: 1000; and anti-VEGFR2 diluted 1: 1000, respectively as the primary antibody, and a 1:600 dilution of anti-goat IgG-horseradish peroxidase (Santa Cruz, Cat # SC-2020) as the secondary antibody
###end p 26
###begin title 27
Quantification of apoptotic cell assay in emphysematous lungs
###end title 27
###begin p 28
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ </italic>
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ </italic>
###xml 129 132 <span type="species:ncbi:9685">Cat</span>
In situ nick end-labeling (TUNEL) was performed using the in situ cell death detection kit, Fluorescein (Roche, Applied Science. Cat. No.11684795910), which was also used for detecting and quantifying apoptosis (programmed cell death) at the single cell level, based on labeling of DNA strand breaks (TUNEL technology). Analysis was performed by fluorescence microscopy according to the manufacturer's instructions and the number of fluorescein-positive cells in the microscopic fields of each section was determined by fluorescence microscope.
###end p 28
###begin title 29
Immuno-histochemical staining for VEGF receptor
###end title 29
###begin p 30
###xml 308 312 <span type="species:ncbi:9925">goat</span>
###xml 428 433 <span type="species:ncbi:10090">mouse</span>
Paraffin-embedded tissue sections were treated with xylene to remove the paraffin, and then dehydrated in ethanol, and re-hydrated in PBS. Endogenous peroxidase activity was neutralized by incubating the sections for 20 min in 3% H2O2. After blocking the non-specific binding sites with 3% BSA and 5% normal goat serum, the section were incubated with primary antibodies for 1 h at room temperature. The primary antibodies were mouse monoclonal antibodies against VEGF R1 and R2 (Chemicon International, Inc. 1: 200 dilutions). Immuno-histochemical staining of VEGF R1 (Flt-1) and R2 (KDR) was done using standard techniques, with negative controls obtained by omitting the primary antibody.
###end p 30
###begin title 31
Statistical analysis
###end title 31
###begin p 32
###xml 195 197 195 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
Statistical analysis was performed using the SPSS 9.0 for Windows (Statistical Package for Social Sciences, Inc., Chicago, IL) and analyzed using the Mann-Whitney test for non-parametric data. A p value < 0.05 was considered statistically significant.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
Morphometric measurements of airspace size
###end title 34
###begin p 35
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
The time course in developing emphysema after PPE instillation was examined in these various genotypes of mice. After 4 weeks of PPE treatment, there was marked alveolar enlargement with breaks in the alveolar walls compatible with destruction of the normal small airway structure in WT mice (Fig. 1). However, this was not present in PlGF KO mice (Fig. 2) and in saline control groups (Fig. 3). The degree of airspace enlargement was reduced in HE mice (Fig. 4).
###end p 35
###begin p 36
###xml 0 160 0 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Photo-micrograph of lung parenchyma after PPE or normal saline treatment - Wide type mice (PlGF +/+) treated with PPE for 4 weeks show alveolar wall destruction</bold>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Photo-micrograph of lung parenchyma after PPE or normal saline treatment - Wide type mice (PlGF +/+) treated with PPE for 4 weeks show alveolar wall destruction.
###end p 36
###begin p 37
###xml 0 144 0 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Photo-micrograph of lung parenchyma after PPE or normal saline treatment - displays marked enlargement of airspace as compared to knock-out mice</bold>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
Photo-micrograph of lung parenchyma after PPE or normal saline treatment - displays marked enlargement of airspace as compared to knock-out mice.
###end p 37
###begin p 38
###xml 0 179 0 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Photo-micrograph of lung parenchyma after PPE or normal saline treatment - also displays marked enlargement of airspace as compared to the control group treated with normal saline</bold>
Photo-micrograph of lung parenchyma after PPE or normal saline treatment - also displays marked enlargement of airspace as compared to the control group treated with normal saline.
###end p 38
###begin p 39
###xml 0 130 0 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The severity of emphysema is considerably less in panel (PlGF +/-, heterozygous type) (original magnification &#215; 40; Bar = 100 &#956;m)</bold>
The severity of emphysema is considerably less in panel (PlGF +/-, heterozygous type) (original magnification x 40; Bar = 100 mum). C: control.
###end p 39
###begin p 40
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 252 264 252 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v(air, lung)</sub>
###xml 384 386 380 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
Upon morphologic quantification of the severity of emphysema by determining mean linear intercepts (MLI), the values of which were significantly greater in WT mice than in KO mice and controls (Fig. 5). Furthermore, the volume density of airspaces (V, v(air, lung); %) was significantly higher in WT mice (87.2 +/- 0.6%) treated with PPE for 4 weeks than the KO mice (71.8 +/- 0.5%) (p < 0.01). PlGF KO mice had less degree in the development of PPE-induced emphysema. Besides, no significant MLI increase was detected in heterozygous and homozygous deficiency mice with saline treatment.
###end p 40
###begin p 41
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emphysema in PPE-treated lung was assessed by mean linear intercept (MLI)</bold>
###xml 197 199 197 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
Emphysema in PPE-treated lung was assessed by mean linear intercept (MLI). MLIs are significantly greater in the wild type and heterogeneous mice, compared to the PlGF KO mice or control groups. (*p < 0.05, C: wide type mice with saline; C+/-: heterozygous mice with saline; C-/-: homozygous deficiency mice with saline). An decrease in MLIs and the degree of emphysematous change correlate with KO mice when compared with Fig. 1B.
###end p 41
###begin title 42
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Decreased MMP-9 and TNF-alpha expression in lungs of PlGF KO mice
###end title 42
###begin p 43
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8</xref>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
To assess if inflammatory mediators were affected in PlGF KO mice, MMP-9 and TNF-alpha expression were analyzed after 4 weeks, as well as VEGF expression. The expressions of both MMP-9 and TNF-alpha were lower in the lungs of PlGF KO mice than in WT mice (Figs. 6 and 7). However, VEGF expression was higher in KO mice than in the WT mice (Fig. 8), which revealed decreased inflammatory reactions but increased vasculature in KO mice after PPE instillation.
###end p 43
###begin p 44
###xml 0 122 0 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELISA and Western blot analysis show higher expression of MMP-9 in PlGF +/+ wild type mice, compared with PlGF -/- KO mice</bold>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
ELISA and Western blot analysis show higher expression of MMP-9 in PlGF +/+ wild type mice, compared with PlGF -/- KO mice.
###end p 44
###begin p 45
###xml 0 126 0 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELISA and Western blot analysis show higher expression of TNF-&#945; in PlGF +/+ wild type mice, compared with PlGF -/- KO mice</bold>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
ELISA and Western blot analysis show higher expression of TNF-alpha in PlGF +/+ wild type mice, compared with PlGF -/- KO mice.
###end p 45
###begin p 46
###xml 76 78 76 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 88 90 88 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 0 211 0 211 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">However, VEGF expression is higher in PlGF KO mice than in wild type mice (*<italic>p </italic>&lt; 0.05; **<italic>p </italic>&lt; 0.01, C: wide type mice with saline; C+/-: heterozygous mice with saline; C-/-: homozygous deficiency mice with saline)</bold>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
However, VEGF expression is higher in PlGF KO mice than in wild type mice (*p < 0.05; **p < 0.01, C: wide type mice with saline; C+/-: heterozygous mice with saline; C-/-: homozygous deficiency mice with saline).
###end p 46
###begin title 47
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Decreased pulmonary septal cell death in lungs of PlGF KO mice
###end title 47
###begin p 48
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">9</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F10">10</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F11">11</xref>
###xml 611 613 607 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
Assessment of apoptotic cells in the alveolar septa normalized by fluorescence microscopy from serial sections revealed an increase in TUNEL (+) cells in emphysematous lungs when compared to those of PlGF KO mice (Figs. 9 and 10). Quantification of the number of apoptotic cells in the alveolar septa normalized by the amount of nucleic acid extracted from serial sections revealed an increase in TUNEL (+) cells in WT emphysematous lungs when compared with the lungs of HE or KO mice (Fig. 11). There were significantly more TUNEL (+) cells in the WT (emphysema, 11.8 +/- 1.2%) than in KO mice (4.2 +/- 1.3%) (p < 0.01).
###end p 48
###begin p 49
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Increased apoptotic cells in the alveolar septa of PlGF WT mice</bold>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Increased apoptotic cells in the alveolar septa of PlGF WT mice.
###end p 49
###begin p 50
###xml 0 221 0 220 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">There is increased terminal deoxynucleotidyl (TdT)-mediated dNTP nick end-labeling (TUNEL)-positive cells (fluorescent, arrows) after a 4-week PPE treatment (original magnification &#215; 40, Bar = 100 &#956;m) compared to KO mice</bold>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
There is increased terminal deoxynucleotidyl (TdT)-mediated dNTP nick end-labeling (TUNEL)-positive cells (fluorescent, arrows) after a 4-week PPE treatment (original magnification x 40, Bar = 100 mum) compared to KO mice.
###end p 50
###begin p 51
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TUNEL-positive cells are counted and represented in the graph</bold>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
TUNEL-positive cells are counted and represented in the graph. There are significantly more TUNEL (+) cells in the emphysema lungs (PPE-treated WT mice) compared to the lungs of HE, KO, and control mice (p < 0.01, C: wide type mice with saline; C+/-: heterozygous mice with saline; C-/-: homozygous deficiency mice with saline). In PlGF KO mice, there is weekly PPE instillation followed by exogenous PlGF at a dose of 1 mg/kg via intra-tracheal route.
###end p 51
###begin title 52
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Re-development emphysema after exogenous PlGF instillation in PPE-treated PlGF KO mice
###end title 52
###begin p 53
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F12">12</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F13">13</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F14">14</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F15">15</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
PlGF KO mice were given weekly PPE instillation followed by exogenous PlGF. Compared without exogenous PlGF therapy (Fig 12), emphysematous changes were detected within 2 weeks of concomitant therapy (Fig 13). Airspace enlargement became more significant after 3-4 weeks. (Figs. 14, 15) Emphysema re-developed after exogenous PlGF instillation in PPE-treated PlGF KO mice, which implied that PlGF contributed to the development of emphysema.
###end p 53
###begin p 54
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KO mice treated with 4 weeks of PPE reveal no marked airspace enlargement</bold>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
KO mice treated with 4 weeks of PPE reveal no marked airspace enlargement.
###end p 54
###begin p 55
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Some emphysematous change is detected at 2 weeks of concomitant therapy</bold>
Some emphysematous change is detected at 2 weeks of concomitant therapy.
###end p 55
###begin p 56
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The airspaces are significantly enlarged after 3 weeks of treatment</bold>
The airspaces are significantly enlarged after 3 weeks of treatment.
###end p 56
###begin p 57
###xml 0 138 0 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The airspaces are markedly larger than before the 4-week treatment, and emphysema re-develops (original magnification &#215; 40, Bar = 100 &#956;m)</bold>
The airspaces are markedly larger than before the 4-week treatment, and emphysema re-develops (original magnification x 40, Bar = 100 mum).
###end p 57
###begin p 58
###xml 254 256 250 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
PPE instillation followed by administration of neutralizing anti-VEGFR1 antibody AF471 decreased the development of emphysema after 4 weeks. The MLIs values decreased by 36% in the AF471 treatment group compared to the controls (78 +/- 17 vs. 60 +/- 18, p = 0.06), which did not reach statistical significance.
###end p 58
###begin title 59
Decreased expression of immuno-histochemical staining for VEGF receptor
###end title 59
###begin p 60
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F16">16</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F17">17</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F18">18</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F19">19</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F20">20</xref>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
In the emphysematous tissues of WT mice treated with 4 week PPE, VEGF R1 (Flt-1) expression decreased as compared to the WT control mice with saline that had no emphysema (Figs. 16 and 17). Moreover, there was reduced VEGF R2 (KDR) expression in lungs with emphysematous changes (Figs. 18 and 19). Western blot analysis also confirmed the reduced expression of these receptors (Fig. 20).
###end p 60
###begin p 61
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Immuno-histochemical staining for VEGF R1 (Flt-1) and VEGF R2 (KDR)</bold>
Immuno-histochemical staining for VEGF R1 (Flt-1) and VEGF R2 (KDR). In Flt-1 expression, these are significantly decreased in emphysematous lungs.
###end p 61
###begin p 62
###xml 0 125 0 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Immuno-histochemical staining for VEGF R1 (Flt-1) and VEGF R2 (KDR) Displays Flt-1 expression comparison in controls (arrows)</bold>
Immuno-histochemical staining for VEGF R1 (Flt-1) and VEGF R2 (KDR) Displays Flt-1 expression comparison in controls (arrows).
###end p 62
###begin p 63
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In KDR expression, these are significantly decreased in emphysematous lungs</bold>
In KDR expression, these are significantly decreased in emphysematous lungs.
###end p 63
###begin p 64
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Displays KDR expression comparison in controls (arrows)</bold>
Displays KDR expression comparison in controls (arrows). (original magnification x 200. Bar = 100 mum).
###end p 64
###begin p 65
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Western blot analysis shows lower VEGFR1 and VEGFR2 expression in emphysematous tissues compared to controls</bold>
Western blot analysis shows lower VEGFR1 and VEGFR2 expression in emphysematous tissues compared to controls.
###end p 65
###begin title 66
Discussion
###end title 66
###begin p 67
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 611 612 611 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 670 685 <span type="species:ncbi:10090">transgenic mice</span>
###xml 715 720 <span type="species:ncbi:9606">human</span>
###xml 753 759 <span type="species:ncbi:9606">humans</span>
Pulmonary emphysema, defined as abnormal airspace enlargement distal to the terminal bronchioles, is a major component of COPD. Although COPD occurs predominantly in smokers, the fact that only 15-20% of smokers develop pulmonary emphysema suggests an interaction of genetic, environmental, and other factors in causing emphysema [18-21]. The protease-anti-protease imbalance and oxidative stress theories related to inflammation are considered the key pathogenesis behind pulmonary emphysema. However, inflammation may not be the sole mechanism. Previously, studies reported the association of VEGF with COPD [8,9]. In addition, Tsao et al. have demonstrated that PlGF transgenic mice develop pathology similar to human pulmonary emphysema, [13] while humans with COPD show elevated PlGF levels in sera and BAL fluids [14]. Taken together, angiogenic growth factors, such as PlGF, may contribute to the development of emphysema.
###end p 67
###begin p 68
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 687 689 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 381 386 <span type="species:ncbi:9606">human</span>
###xml 575 580 <span type="species:ncbi:10090">mouse</span>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
The current study demonstrates that PlGF KO mice are protected from developing elastase-induced emphysema. It also shows lower apoptosis cell counts in PlGF KO mice that did not develop emphysema, when compared to WT mice that developed emphysema. Based on previous findings [14], persistent PlGF treatment, combined with TNF-alpha and IL-8, induces the down-regulation of VEGF in human bronchial epithelial cells, most likely through reduced number of viable cells and increased cell apoptosis. Tsao et al. have shown that PlGF inhibits the proliferation of MLE-15 cells (a mouse pulmonary type II epithelial cell line) in a dose-dependent manner and significantly promotes cell death [13]. Findings in cell culture studies are compatible with those from animals. Moreover, intra-tracheal instillation of exogenous PlGF in elastase-treated PlGF KO mice re-develops the emphysematous pattern. We thought that PlGF is essential in the pathogenesis of emphysema and is related to apoptosis.
###end p 68
###begin p 69
###xml 42 51 42 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 220 228 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 746 748 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
Previously, it has been demonstrated that in vitro chronic stimulation of epithelial cells with PlGF and other cytokines induce cell death and apoptosis, which is similar to exposure to chronic irritants associated with in vivo lung parenchymal damage [14]. A VEGFR inhibitor in a concentration that mainly blocks VEGF R1 abolished this phenomenon [14]. In this study, VEGF receptors, including VEGF R1 and R2, have decreased expression in emphysematous tissues. It is speculated that inflammatory cytokines (i.e. TNF-alpha, IL-8) and PlGF-induced alveolar cell apoptosis reduce the expression of VEGF and down-regulate VEGFR. These result in fewer endothelial cells and thin, avascular alveolar septum that are compatible with Liebow's opinion [22].
###end p 69
###begin p 70
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 608 613 <span type="species:ncbi:9606">human</span>
Recent studies pointed out that the failure to maintain alveolar structure and lung apoptosis contributes to the development of emphysema [23,24]. The defective homeostasis of one or more cell types elicit emphysematous changes. For instance, when VEGF, which is abundant in the lungs, is neutralized in animal models, the result is an apoptosis-dependent enlargement of airspaces and structural changes similar to emphysema [25-27], not only by induction of apoptosis of type II pneumocytes but also by impaired production of surfactant [13,28]. An increasing number of data, from animal models, studies on human subjects, and cell culture experiments, supports an important role for apoptosis in the pathogenesis of emphysema. Thus, several disease mechanisms are involved in the process, including inflammation, proteinase-anti-proteinase imbalance, and oxidative stress. Apoptosis interacts with all of these pathways, adding to the complexity of the disease.
###end p 70
###begin p 71
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 516 524 <span type="species:ncbi:9606">patients</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
PlGF expression increases significantly in early gestation, peaks at around 26-30 weeks, and decreased as term approaches [29]. However, the biological function of PlGF after gestation and in adulthood remains unclear. Although the synergism between VEGF and PlGF contributes to angiogenesis and plasma extravasation in pathologic conditions such as ischemia or inflammation [15], it has been demonstrated that the bronchial epithelial cells can express PlGF and elevated levels of PlGF have harmful effects in COPD patients [14]. This animal study shows that PlGF KO mice are protected against emphysema. Since persistent and elevated PlGF levels may induce pulmonary cell damage, inhibiting PlGF offers opportunities for blocking the development of emphysema.
###end p 71
###begin p 72
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
Several animal models of COPD development have been previously studied. Compared to the chronic smoke exposure model, the model of elastase-induced emphysema develops more acutely, even though it may have more limited clinical relevance, which included small airway disease (bronchiolitis), airflow limitation, COPD exacerbation, systemic inflammation and extrapulmonary manifestation. Some animal studies demonstrate that inhibiting VEGFRs causes alveolar wall or endothelial cell apoptosis, which is sufficient to cause emphysema. However, this does not lead to any accumulation of inflammatory cells [26,30] or VEGF [31]. In the PPE-instillation emphysema animal model, there is a substantial inflammatory response (MMP and TNF-alpha) accompanied by an increase in cellular apoptosis and down-regulation of VEGF levels, which are all relevant pathologic characteristics of COPD.
###end p 72
###begin p 73
###xml 22 31 22 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
Based on the previous in vitro study, the chronic activation of epithelial cells with PlGF and other cytokines induces cell death and apoptosis, which can be abolished by a VEGF R1 inhibitor [14]. In this study, exogenous VEGF R1 blocker prevented emphysema in mice, with a trend of decreased level of airspace enlargement. However, the decrease expression of VEGF R1 and R2 in emphysema tissues had not been expected. Aside from receptor blockers, more studies should be performed to test whether apoptosis can be a therapeutic target to prevent emphysema.
###end p 73
###begin p 74
###xml 129 133 <span type="species:ncbi:10090">mice</span>
In conclusion, this study demonstrates the hypothesis that blocking PlGF can prevent the development of PPE-induced emphysema in mice. The pathogenesis may be related to the apoptosis. A VEGF R1 blocker partially inhibited the action of exogenous PlGF and caused re-development of emphysema. Identifying the cellular and molecular mechanisms in the pathogenesis of emphysema and apoptosis should have important implications in developing new targets for therapeutic intervention of COPD.
###end p 74
###begin title 75
Competing interests
###end title 75
###begin p 76
The authors declare that they have no competing interests.
###end p 76
###begin title 77
Authors' contributions
###end title 77
###begin p 78
###xml 216 220 <span type="species:ncbi:10090">mice</span>
SLC carried out the animal studies, participating molecular biology experiments and drafted the manuscript. SJC carried out the apoptosis with TUNEL stain. PC and PNT participated in the source of the gene-deficient mice. SLC and HCW participated in the design of the study and performed the statistical analysis. CJY and PCY conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 78
###begin title 79
Acknowledgements
###end title 79
###begin p 80
This study was supported by grants from the Far Eastern Memorial Hospital FEMH-95-C-005 (to S.L.C.), and NSC 94-2321-B-002-146- and NSC 95-2314-B-002-044 (to. P.N.T.).
###end p 80
###begin article-title 81
###xml 0 7 <span type="species:ncbi:4097">Tobacco</span>
Tobacco: the growing epidemic
###end article-title 81
###begin article-title 82
Amplification of inflammation in emphysema and its association with latent adenoviral infection
###end article-title 82
###begin article-title 83
The nature of small-airway obstruction in chronic obstructive pulmonary disease
###end article-title 83
###begin article-title 84
Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema
###end article-title 84
###begin article-title 85
Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by alpha1-antitrypsin
###end article-title 85
###begin article-title 86
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease
###end article-title 86
###begin article-title 87
###xml 118 122 <span type="species:ncbi:10090">mice</span>
Acute cigarette smoke induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice
###end article-title 87
###begin article-title 88
Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema
###end article-title 88
###begin article-title 89
###xml 71 74 <span type="species:ncbi:10116">rat</span>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition
###end article-title 89
###begin article-title 90
###xml 15 20 <span type="species:ncbi:9606">human</span>
Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
###end article-title 90
###begin article-title 91
Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic
###end article-title 91
###begin article-title 92
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
The placenta growth factor gene of the mouse
###end article-title 92
###begin article-title 93
Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema
###end article-title 93
###begin article-title 94
Increased expression of placenta growth factor in COPD
###end article-title 94
###begin article-title 95
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
###end article-title 95
###begin article-title 96
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1 beta receptor-deficient mice
###end article-title 96
###begin article-title 97
Stereological methods: a new approach in the assessment of pulmonary emphysema
###end article-title 97
###begin article-title 98
Vascular atrophy and VEGFR-2 signaling: old theories of pulmonary emphysema meet new data
###end article-title 98
###begin article-title 99
Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers
###end article-title 99
###begin article-title 100
Association of tumor necrosis factor alpha gene polymorphism with the presence of chronic obstructive pulmonary disease
###end article-title 100
###begin article-title 101
Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD
###end article-title 101
###begin article-title 102
Pulmonary emphysema with special reference to vascular change
###end article-title 102
###begin article-title 103
Patho-biology of cigarette smoke-induced chronic obstructive pulmonary disease
###end article-title 103
###begin article-title 104
Role of apoptosis the pathogenesis of COPD and pulmonary emphysema
###end article-title 104
###begin article-title 105
Clinical implications for vascular endothelial growth factor in the lung: friend or foe?
###end article-title 105
###begin article-title 106
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Lung-targeted VEGF in activation leads to an emphysema phenotype in mice
###end article-title 106
###begin article-title 107
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
###end article-title 107
###begin article-title 108
Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung
###end article-title 108
###begin article-title 109
Preeclampsia is associated with reduced serum levels of placenta growth factor
###end article-title 109
###begin article-title 110
Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade
###end article-title 110
###begin article-title 111
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice
###end article-title 111

